Prophylactic early low-dose hydrocortisone and survival without bronchopulmonary dysplasia among extremely preterm infants born at 22-27 weeks' gestation.
Sanket D ShahSamarth ShuklaP Sireesha NandulaShannon ViceMarwa M ElgendyShiva GautamMark L HudakJosef CortezPublished in: Journal of perinatology : official journal of the California Perinatal Association (2024)
After risk adjustment, PEH-treated infants demonstrated improved survival without BPD and did not increase rates of bowel perforation or sepsis. In our cohort of infants, PEH was safe and effective among the sickest preterm neonates.